Inogen Inc.
INGN | NASDAQ
$5.13
+$0.03 (+0.59%)
Sep 22, 2026, 2:45 PM ET · Market open
Company Profile
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Key Executives
| Name | Position |
|---|---|
| Kevin R. Smith | President, Chief Executive Officer & Director |
| Dominic Hulton | Chief Marketing Officer |
| Naga Rameswamy | Chief Technology Officer |
| Andrew Reding | Executive VP & COO |
| Grgoire Ramade | Executive Vice President & Chief Commercial Officer |
| Jason A. Richardson | CFO, Executive VP & Treasurer |
| Jennifer Yi Boyer | Executive Vice President of Enterprise Enablement & Chief Human Resources Officer |
| Kevin Smith | General Counsel, Secretary & Executive Vice President of Business Development |
| Lorna Williams | Senior Vice President of Investor Relations |
| Mary Wright | VP & Chief Accounting Officer |
| Philip Corrin | Senior Vice President of Operations & Supply Chain |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Aug 07, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 24, 2026 | S-8 | Filing |
| Jul 09, 2026 | 4 | Filing |
| Jul 09, 2026 | 3 | Filing |
| Jul 06, 2026 | 4 | Filing |
| Jul 01, 2026 | 8-K | Current Report |
Inogen Inc.
| Country | United States |
| IPO Date | Feb 13, 2014 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 753 |
| CEO | Kevin R. Smith |
Contact Details
500 Cummings Center Beverly,
Massachusetts 01915 United States
Stock Details
| Ticker Symbol | INGN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001294133 |
| CUSIP Number | 45780L104 |
| ISIN Number | US45780L1044 |
| SIC Code | 3842 |
Add to Watchlist
Select watchlists to add or remove INGN